Steven Cohen Merck & Co., Inc. Call Options Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $3.42 Million - $3.97 Million	30,800 Added 130.51%	54,400 $6.18 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $222,840 - $239,328	-1,800 Reduced 7.09%	23,600 $2.92 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $16.5 Million - $19.2 Million	-145,800 Reduced 85.16%	25,400 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $4.5 Million - $4.89 Million	44,900 Added 35.55%	171,200 $18.7 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $13 Million - $14.4 Million	126,300 New	126,300 $13 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $2.75 Million - $3.07 Million	-26,700 Reduced 80.18%	6,600 $702,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $2.91 Million - $3.73 Million	33,300 New	33,300 $3.69 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $103 Million - $115 Million	1,395,000 Added 155.0%	2,295,000 $188 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $28.1 Million - $31.1 Million	400,000 Added 80.0%	900,000 $70 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $151 Million - $178 Million	-2,200,000 Reduced 81.48%	500,000 $38.5 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $96.8 Million - $113 Million	1,900,000 Added 237.5%	2,700,000 $147 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $36.1 Million - $43.1 Million	-700,000 Reduced 46.67%	800,000 $45 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $88 Million - $94.7 Million	1,500,000	1,500,000 $96 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.